Article History
Received: 30 July 2019
Accepted: 27 April 2020
First Online: 4 May 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: LJR: None to declare.SK: None to declare.YBZ: Yael Bar-Zeev has received fees for lectures from Pfizer Israel Ltd. (distributor of a smoking cessation pharmacotherapy in Israel) in 2012–2015 and 2017–07/2019. She has also received fees for lectures from Novartis (past distributor of nicotine replacement therapy in Israel) in the past (2012–2015), and from GSK Consumer Health (distributor of nicotine replacement therapy in Israel) in 07/2019.HL: HL received fees for lectures from Pfizer Israel Ltd. (2017).The authors were involved in the legislative progress, including attendance at Knesset meetings, direct contacts with Knesset members and their aids, and media appearances.